Literature DB >> 33230339

Liquid biopsy versus tumor biopsy for clinical-trial recruitment.

Ryan B Corcoran1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33230339     DOI： 10.1038/s41591-020-01169-6

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

Review 1.  Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management.

Authors:  Mohammad Aslam Khan; Kunwar Somesh Vikramdeo; Sarabjeet Kour Sudan; Seema Singh; Annelise Wilhite; Santanu Dasgupta; Rodney Paul Rocconi; Ajay Pratap Singh
Journal:  Semin Cancer Biol       Date:  2021-08-18       Impact factor: 15.707

2.  Acquired EGFR C797G Mutation Detected by Liquid Biopsy as Resistance Mechanism After Treatment With Osimertinib: A Case Report.

Authors:  Elisa DE Carlo; Monica Schiappacassi; Giacomo Pelizzari; Tania Baresic; Alessandro Del Conte; Brigida Stanzione; Valentina DA Ros; Roberto Doliana; Gustavo Baldassarre; Alessandra Bearz
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.155

3.  Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.

Authors:  Fangfang Shen; Naixin Liang; Zaiwen Fan; Min Zhao; Jing Kang; Xifang Wang; Qun Hu; Yongping Mu; Kai Wang; Mingming Yuan; Rongrong Chen; Wei Guo; Guilan Dong; Jun Zhao; Jun Bai
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

4.  Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid.

Authors:  Jinfang Zhai; Songyan Han; Qinxiang Guo; Binbin Shan; Jing Wang; Yanrong Guo; Guoping Tong; Chang Zhao; Yuan Li; Qiao Han; Xiaoqin An; Ruiqing Yue; Li Wang; Tingting Guo; Zhentian Liu; Yaping Xu; Jianqiang Li; Weihua Yang
Journal:  Front Oncol       Date:  2021-04-26       Impact factor: 6.244

Review 5.  The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma.

Authors:  Luigi Fattore; Ciro Francesco Ruggiero; Domenico Liguoro; Vittorio Castaldo; Angiolina Catizone; Gennaro Ciliberto; Rita Mancini
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

6.  Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling.

Authors:  Hai T Tran; Vincent K Lam; Yasir Y Elamin; Lingzhi Hong; Rivka Colen; Nabil A Elshafeey; Islam S A Hassan; Mehmet Altan; George R Blumenschein; Waree Rinsurongkawong; Melvin J Rivera; Mayra E Vasquez; Brett W Carter; Lauren E Byers; Anne S Tsao; Don L Gibbons; Frank Fossella; Bonnie S Glisson; Jianjun Zhang; John V Heymach
Journal:  JCO Precis Oncol       Date:  2021-08-05

7.  Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma.

Authors:  Haitang Yang; Beibei Sun; Liwen Fan; Wenyan Ma; Ke Xu; Sean R R Hall; Zhexin Wang; Ralph A Schmid; Ren-Wang Peng; Thomas M Marti; Wen Gao; Jianlin Xu; Weiwei Yang; Feng Yao
Journal:  Theranostics       Date:  2022-03-28       Impact factor: 11.600

Review 8.  Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer.

Authors:  Ulka N Vaishampayan; Pedro C Barata; Albert Jang; Grant P Rauterkus
Journal:  Onco Targets Ther       Date:  2022-08-26       Impact factor: 4.345

Review 9.  Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers - current evidence and future directions.

Authors:  Rachel C T Lam; David Johnson; Gigi Lam; Michelle L Y Li; Joyce W L Wong; W K Jacky Lam; K C Allen Chan; Brigette Ma
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

Review 10.  Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development.

Authors:  Timothé Ménard; Alaina Barros; Christopher Ganter
Journal:  Ther Innov Regul Sci       Date:  2021-05-27       Impact factor: 1.778
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.